Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments

Data Availability

Data supporting the findings of this study are available within Supplementary Information files. SARS-CoV-2 genome sequences obtained in the project were submitted to GISAID. Trimmed read data generated and used for identification of emerging de novo Spike RBD mutants in this study have been submitted to the European Nucleotide Archive (ENA) under the project accession PRJEB55794. All other data generated in this study are available from the corresponding author upon request.